(Q51894912)

17 April 2018

title

Preponderance of sonic hedgehog pathway activation characterizes adult medulloblastoma. (English)

1 reference

17 April 2018

0 references

Hani Al-Halabi

1

1 reference

17 April 2018

Andre Nantel

2

1 reference

17 April 2018

Almos Klekner

3

1 reference

17 April 2018

Marie-Christine Guiot

4

1 reference

17 April 2018

Steffen Albrecht

5

1 reference

17 April 2018

Peter Hauser

6

1 reference

17 April 2018

Miklos Garami

7

1 reference

17 April 2018

Laszlo Bognar

8

1 reference

17 April 2018

Peter Kavan

9

1 reference

17 April 2018

Noha Gerges

10

1 reference

17 April 2018

Margret Shirinian

11

1 reference

17 April 2018

David Roberge

12

1 reference

17 April 2018

Thierry Muanza

13

1 reference

17 April 2018

Nada Jabado

14

1 reference

17 April 2018

publication date

24 November 2010

1 reference

17 April 2018

published in

Acta Neuropathologica

1 reference

17 April 2018

volume

121

1 reference

17 April 2018

issue

2

1 reference

17 April 2018

page(s)

229-239

1 reference

17 April 2018

https://scigraph.springernature.com/pub.10.1007/s00401-010-0780-0

exact match

0 references

cites work

Characteristics and outcomes of medulloblastoma in adults.

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Medulloblastoma in adults: clinical characteristics and treatment.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Reappraisal of clinical outcome in adult medulloblastomas with emphasis on patterns of relapse.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Wnt/Wingless pathway activation and chromosome 6 loss characterize a distinct molecular sub-group of medulloblastomas associated with a favorable prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Molecular risk stratification of medulloblastoma patients based on immunohistochemical analysis of MYC, LDHB, and CCNB1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

What's new in neuro-oncology? Recent advances in medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

beta-Catenin status predicts a favorable outcome in childhood medulloblastoma: the United Kingdom Children's Cancer Study Group Brain Tumour Committee

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Childhood medulloblastoma: novel approaches to the classification of a heterogeneous disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Molecular profiling identifies prognostic subgroups of pediatric glioblastoma and shows increased YB-1 expression in tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Clinical, histopathologic, and molecular markers of prognosis: toward a new disease risk stratification system for medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Gene expression profiling from formalin-fixed paraffin-embedded tumors of pediatric glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Adult cerebellar medulloblastomas: the pathological, radiographic, and clinical disease spectrum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Integrated genomics identifies five medulloblastoma subtypes with distinct genetic profiles, pathway signatures and clinicopathological features

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Adult and pediatric medulloblastomas are genetically distinct and require different algorithms for molecular risk stratification

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Medulloblastoma in children and in adults: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Nodule formation and desmoplasia in medulloblastomas-defining the nodular/desmoplastic variant and its biological behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Modeling radiation dosimetry to predict cognitive outcomes in pediatric patients with CNS embryonal tumors including medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Phase III study of craniospinal radiation therapy followed by adjuvant chemotherapy for newly diagnosed average-risk medulloblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Common strategy for adult and pediatric medulloblastoma: a multicenter series of 253 adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Outcome prediction in pediatric medulloblastoma based on DNA copy-number aberrations of chromosomes 6q and 17q and the MYC and MYCN loci

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Molecular diagnostics of CNS embryonal tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Prediction of central nervous system embryonal tumour outcome based on gene expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Genome-wide profiling using single-nucleotide polymorphism arrays identifies novel chromosomal imbalances in pediatric glioblastomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Histopathologic grading of adult medulloblastomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Treatment of medulloblastoma with hedgehog pathway inhibitor GDC-0449

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Are childhood and adult medulloblastomas different? A comparative study of clinicopathological features, proliferation index and apoptotic index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Medulloblastoma in the second decade of life: a specific group with respect to toxicity and management: a Canadian Pediatric Brain Tumor Consortium Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Distinctive clinical course and pattern of relapse in adolescents with medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Universal poor survival in children with medulloblastoma harboring somatic TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

Genomics identifies medulloblastoma subgroups that are enriched for specific genetic alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00401-010-0780-0

10.1007/S00401-010-0780-0

21 January 2018

Identifiers

DOI

1 reference

17 April 2018

1 reference

17 April 2018